21 CFR § 864.7720 Hematology and Pathology Devices

§ 864.7720 Prothrombin consumption test.

Current through Sep 8, 2026 · Read all of Part 864

(a) Identification. A prothrombin consumption tests is a device that measures the patient's capacity to generate thromboplastin in the coagulation process. The test also is an indirect indicator of qualitative or quantitative platelet abnormalities. It is a screening test for thrombocytopenia (decreased number of blood platelets) and hemophilia A and B.

(b) Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

[45 FR 60625, Sept. 12, 1980, as amended at 84 FR 71800, Dec. 30, 2019]

← § 864.7695 Platelet factor 4 radioimmunoassay.§ 864.7735 Prothrombin-proconvertin test and thrombotest. →